M. Regina Castro, MD, Mayo Clinic Medical School – WIT President.
Dr. M. Regina Castro is an Associate Professor of Medicine at Mayo Clinic Medical School, and consultant in the Division of Endocrinology at Mayo Clinic, where she has served as Associate Program Director of Endocrinology Fellowship Program and the Director of Internal Medicine Residency Rotation in Endocrinology.
She has been a member of the ATA since 2000 (prior to that was associate member since 1998).
She has served in the ATA in many capacities, including as a member of:
Trainees and career advancement committee, Editorial Board of Clinical Thyroidology for the public, Board Liaison to the Clinical Affairs committee, ATA awards committee, Board of Directors from 2014-2018, Chair of the Patient Education and Affairs committee since 2015 to present.
She is a member of the Mayo Clinic Thyroid Core group.
Her research interests are in the areas of thyroid nodules, thyroid cancer and novel non-surgical therapies for benign thyroid nodules.
Over her career she has mentored many Endocrinology Fellows, mostly young women, the majority of whom have moved on to pursue very successful careers in Academic endocrinology.
Angela M. Leung, MD, UCLA and VA Greater Los Angeles – WIT President-Elect
Angela M. Leung, MD, MSc is an Associate Professor of Medicine in the Division of Endocrinology, Diabetes, and Metabolism at the UCLA David Geffen School of Medicine and the VA Greater Los Angeles Healthcare System. After pursuing her undergraduate studies at Occidental College, Dr. Leung completed her internal medicine residency and endocrinology fellowship training at Boston University School of Medicine and Boston Medical Center. She also obtained a master’s degree in Epidemiology from the Boston University School of Public Health. Dr. Leung has particular clinical and research interests in iodine status, environmental thyroid toxicants, and maternal-child thyroid health. Within the American Thyroid Association (ATA), she has served on the Patient Education and Advocacy Committee, is a past chair of the Public Health Committee, and has participated in several Annual Meeting Program Organizing Committees, including having served as the Clinical Co-Chair of the 2017 Annual Meeting in Victoria, British Columbia. She currently serves on the board of directors of the ATA and is the board liaison of the ATA’s Diversity, Equity, and Inclusion Task Force. Finally, she is currently Editor-in-Chief of Clinical Thyroidology, one of the ATA’s journals, and a member of the ATA Differentiated Thyroid Cancer guidelines writing committee. Dr. Leung is a strong advocate for supporting the career development and involvement of early career members and trainees in the ATA; promoting the platform and ideas of the DEI movement; and helping foster an even stronger and collegial professional society for all its members.
Megan R. Haymart, MD, University of Michigan – WIT Past-President
Megan R. Haymart, MD, is an Associate Professor of Medicine at the University of Michigan with a primary appointment in the Division of Metabolism, Endocrinology, and Diabetes and a secondary appointment in the Division of Hematology/Oncology. Dr. Haymart’s research focuses on variation in the management of thyroid cancer with an emphasis on the role of patients, providers, and health systems in thyroid cancer diagnosis and treatment. She also studies thyroid cancer outcomes and the rise in thyroid cancer incidence. She is Principal Investigator of the NCI-funded R01 grant “Treatment Decision Making in Low-Risk Thyroid Cancer” and the AHRQ-funded R01 grant “Imaging Practices and Overdiagnosis of Thyroid Cancer”.
Dr. Haymart received her medical degree from Johns Hopkins University School of Medicine in 2002, completed internal medicine residency at Johns Hopkins Hospital in 2005, and then completed fellowship in endocrinology, diabetes and metabolism at the University of Wisconsin in 2007. In 2009, she joined the University of Michigan faculty as Assistant Professor of Medicine and in 2017 she was promoted to Associate Professor of Medicine. Dr. Haymart is involved in creating the National Comprehensive Cancer Network thyroid carcinoma guidelines, is on the Board of Directors for the American Thyroid Association, serves on the editorial board for the Journal of Clinical Oncology, and is Associate Editor for Thyroid.
Debbie Chen, MD, University of Michigan
Debbie Chen, MD is a clinical lecturer in the Division of Metabolism, Endocrinology, and Diabetes at the University of Michigan from which she received her fellowship training in endocrinology. Dr. Chen is interested in studying health and healthcare disparities in the management of patients with thyroid cancer. She received her medical degree from the University of Rochester School of Medicine and Dentistry in 2015 and completed residency training in internal medicine at Thomas Jefferson University Hospital in 2018.
Sophie Dream, MD, Medical College of Wisconsin
Sophie Dream, MD grew-up in Ohio and completed her undergraduate coursework at the University of Cincinnati. She began her medical education at the University of Cincinnati, College of Medicine, graduating in 2013. She completed her surgical residency at Henry Ford Hospital and went on to finish her endocrine surgery fellowship at the University of Alabama at Birmingham. Dr. Dream’s clinical interests include endocrine and neuroendocrine disease with a focus on thyroid and parathyroid disorders. Her research interests focus on health services research and outcomes in patients with endocrine disorders, including hyperparathyroidism and thyroid cancer.
Natalia Genere, MD, Washington University in Saint Louis
Natalia Genere, MD is currently an Instructor of Medicine at Washington University in Saint Louis. She recently graduated from fellowship at the Mayo Clinic in Rochester, MN, where she had excellent role models for women’s leadership and clinical excellence in thyroidology and beyond. At Washington University, Natalia is developing a thyroid focused practice and hope to develop inter-departmental connections with Endocrine Surgery, Ophthalmology, ENT, Pathology, and Radiology to care for patients with thyroid disease. She is thrilled to become part of WIT and to contribute to its crucial mission for the field of thyroidology.
Michele Merten, APRN, Mayo Clinic
Michele Merten, APRN, clinical practice interests include indeterminate thyroid nodules, papillary thyroid cancer, and survivorship care for patients with well-differentiated thyroid cancer. Developed a low-risk thyroid cancer survivorship clinic within endocrinology and continue to seek ways to improve care and management for thyroid cancer survivors. Helped create algorithm of care for thyroid cancer survivorship through Ask Mayo Expert. Michele is an active member of the American Thyroid Association (ATA), serves on the ATA’s Patient Affairs and Education Committee, and served on the ATA’s Diversity, Equity and Inclusion Task Force and Internet Communications Committee. She is also a member of the American Academy of Nurse Practitioners and Association of Southeastern Minnesota Nurse Practitioners. Michele continue to promote advancement of the nursing profession as an Assistant Professor at Viterbo University in the Doctor of Nursing Practice (DNP) program and was co-chair to the First Annual Symposium for Advanced Practice Providers held at the American Thyroid Association meeting in October 2018.
Jennifer Perkins, MD, MBA, Duke University
Jennifer Perkins, MD, MBA is an Associate Professor of Medicine at Duke University Health System in the Division of Endocrinology, Diabetes and Metabolism and has been on faculty since 2009. She attended medical school at Dartmouth School of Medicine then went on to complete internship and residency in internal medicine at Virginia Commonwealth University. Following that she completed a 3 year research fellowship in Endocrinology at Vanderbilt University prior to joining faculty at Duke University. Dr. Perkins has also obtained her Masters in Business Administration at Duk e’s Fuqua School of Business. Her clinical focus is in Endocrine Neoplasia, particularly thyroid nodule and thyroid cancer. She also participates in health outcomes research in this area and has published several peer reviewed articles and book chapters in this arena. She has had several leadership roles including being the associate program director for the Endocrine Fellowship, the Vice Chief for clinical affairs for the Division of Endocrinology and is now currently the Medical Director of Access Services for Duke University Health System. She is a very active clinician and teacher.
Lourdes Quintanilla-Dieck, MD, Oregon Health & Science University
Dr. Lourdes Quintanilla-Dieck completed her medical school in her hometown of Monterrey, Mexico. She then went on to do a research fellowship at the Genetics Department at Harvard Medical School. She completed her Otolaryngology residency at Oregon Health & Science University and is board certified in Otolaryngology – Head and Neck Surgery. She received endocrine surgery training during residency while working closely with Dr. Maisie Shindo and developed a special interest in head and neck endocrine surgery. She then pursued subspecialty training in Pediatric Otolaryngology at Vanderbilt University. Dr. Quintanilla returned to join the Thyroid and Parathyroid Center surgical team at OHSU, and sees both adult and pediatric patients with thyroid conditions. She completed the American College of Surgeons Thyroid and Parathyroid Ultrasound Course at Stanford University, and is co-director of the Doernbecher Children’s Hospital multidisciplinary Pediatric Thyroid Nodule clinic, working in conjunction with the Pediatric Endocrinology division. Dr. Quintanilla’s research interests include thyroid pathology, with a special research focus on pediatric thyroid conditions including nodules and cancer.
Rebecca Schweppe, PhD, University of Colorado School of Medicine
Rebecca Schweppe, PhD is an Associate Professor at the University of Colorado Anschutz Medical Campus. Dr. Schweppe’s research is directed toward identifying novel molecular targets relevant to thyroid cancer, with a specific focus on the role of the Focal Adhesion Kinase-Src pathway. In 2008, Dr. Schweppe published that the majority of thyroid cancer cell lines that had been used by labs around the world for the past 20 years were misidentified with cell lines from other tumor types. This 2008 landmark study led to the global re-examination of thyroid cancer cell lines. Dr. Schweppe has successfully competed for THANC-ATA pilot funding, K12, ACS, R01, and ARRA-Challenge grant funding. In 2013, Dr. Schweppe was recognized with a “Rising Star” outstanding junior faculty award from the University of Colorado, Department of Medicine for excellence in research and teaching. Dr. Schweppe is committed to training PhD and MD scientists, and in 2014, she received an Outstanding Faculty Sponsor award from the University of Colorado graduate school. Since joining the ATA in 2007, Dr. Schweppe has served on the ATA Research Committee (2011-2014), Research Affairs Task Force (2012-present), the Thyroid Editorial board (2013-present), strategic planning retreats, Board of Directors (2015-2019), the Secretary/COO search task force (2018), and the Executive Director search task force (2019-2020).
Naykky Singh Ospina, MD, University of Florida
Naykky Singh Ospina, MD, is an endocrinologist and healthcare researcher at the University of Florida. Her career goal is to improve the quality of care received by patients with endocrine disorders by focusing on providing excellent clinical care, conducting clinical research, and educating our trainees. So far, Naykky has focused on 1) understanding the quality of evidence that guides clinical care 2) developing tools to support shared decision making and 3) evaluating how implementation science can help translate evidence into practice. In fact, she currently holds a career development award by the National Cancer Institute to improve the quality of care of patients with thyroid nodules by supporting shared decision making. She completed medical school at the University of Panama, Internal medicine residency at the John Stroger Hospital of Cook County and Endocrinology fellowship at Mayo Clinic.
Jessica R. Smith, MD, Boston Children’s Hospital
Jessica R. Smith, MD, is an Associate Professor of Pediatrics at Harvard Medical School in the Division of Endocrinology at Boston Children’s Hospital. She received her medical degree at Tufts University and completed her pediatrics internship and residency at Boston Children’s Hospital and Boston Medical Center. Following, she completed a three-year fellowship in Endocrinology at Boston Children’s Hospital with an additional year focusing on Thyroidology at Brigham and Women’s Hospital. She has dedicated her pediatric endocrine career to develop her expertise in pediatric thyroid disorders. Jessica accomplished this through intensive clinical care, research, and teaching with a significant emphasis on Graves’ disease and thyroid neoplasia in children and adolescents. Her interest in thyroidology began while working in a basic science laboratory studying the natural history of TSH receptor autoantibodies in children and adolescents with Graves’ disease under the mentorship of Dr. Rosalind Brown and Dr. Stephen Huang. Jessica now serves as the Associate Medical Director of the Thyroid Center at Boston Children’s Hospital. In this capacity, she led several innovative efforts to optimize the care and treatment of children with thyroid disorders. As Associate Medical Director of the Thyroid Center, Jessica co-lead one of the first and largest multidisciplinary pediatric Thyroid Nodules and Cancer Programs in the nation. She also established and implemented an innovative, hospital-wide, perioperative thyroidectomy protocol designed to detect postoperative hypocalcemia. From a teaching perspective, Jessica enjoys mentoring medical students, residents, and fellows and look forward to further enhancing women in the field of thyroidology.